Neither am I, gems like NEU are rare so there's no way I'm letting go of this easily.
The fact there are still sellers below $40 in the order book is beyond my comprehension...
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.9%
!
$13.90

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-38
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.90 |
Change
1.360(10.9%) |
Mkt cap ! $1.728B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $7.244M | 531.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 827 | $13.89 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.90 | 726 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 181 | 13.850 |
6 | 439 | 13.840 |
2 | 339 | 13.830 |
3 | 1094 | 13.820 |
3 | 585 | 13.810 |
Price($) | Vol. | No. |
---|---|---|
13.870 | 312 | 2 |
13.880 | 175 | 3 |
13.890 | 228 | 3 |
13.900 | 404 | 3 |
13.910 | 1077 | 3 |
Last trade - 11.34am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online